Effectiveness of Nature Walks in Depressed Adults
Investigations of Immediate and Short-term Effects of Nature Walks on Stress and Depression-related Symptoms
1 other identifier
interventional
47
1 country
1
Brief Summary
Over the past few years, a growing number of campaigns from around the world, including Canada, are highlighting the positive impact of spending time in nature on well-¬being. Indeed, mounting evidence suggests that spending time with nature is associated with a myriad of affective and cognitive benefits. Surprisingly few studies to date have tested the assumption that walking in nature versus in urban settings could alleviate stress and depressive symptoms in clinically depressed adults. The main purpose of this study is to investigate the effectiveness of walking in nature versus in urban settings to improve depression related symptoms and reduce stress. The trial initially included 2 primary outcomes: patients stress levels (salivary cortisol) and depression-related symptoms (eg, affect, rumination, executive functioning). However, due to hygienic concerns in light of the COVID-19 pandemic in 2020, the collection of saliva samples (and in turn, the measurement of stress levels via salivary cortisol) was removed from the study's procedure. The main outcome was changed to effects on positive and negative affect.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 18, 2019
CompletedStudy Start
First participant enrolled
June 18, 2019
CompletedFirst Posted
Study publicly available on registry
June 25, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 3, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 3, 2021
CompletedNovember 12, 2021
November 1, 2021
2.2 years
June 18, 2019
November 5, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in affect from baseline up to 48 hours post-walk
Positive and Negative Affect Schedule (PANAS)
Day 1 to Day 3
Secondary Outcomes (5)
Change in Executive Functions
The Stroop test will be administered at 2 time points: 1) before the walk (between 9:45-10:30); 2) after the walk (between 11:30-11:50)
Change in suicidal Ideations
Day 1
Change in depressive symptoms
Day 1 to Day 2
Change in rumination
Day 1
Change in irritability
Day 1 to Day 3
Study Arms (2)
Urban
ACTIVE COMPARATORPatients will go for a silent 60-minute walk in an urban setting. The walk will take place in the months of June, July, August and September between 10:00 to 11:00 am. Participants will walk in groups of two to three participants accompanied by two research assistants trained in mental health (doctoral students in psychology). The urban walk will be located on Boulevard de la Vérendrye with large arteries with three to four lanes.
Nature
EXPERIMENTALPatients will go for a silent 60-minute walk in a nature park setting. The walk will take place in the months of June, July, August and September between 10:00 to 11:00 am. Participants will walk in groups of two to three participants accompanied by two research assistants trained in mental health (doctoral students in psychology). The nature walk will take place at Parc Angrignon, an area of 96 hectares, one of Montreal's largest green and biodiverse spaces with a forest of 20 000 trees and a pond surrounded by willow trees.
Interventions
Eligibility Criteria
You may qualify if:
- Men and women aged between 18 and 65 years, inclusively;
- Ability to speak French or English;
- Diagnosis major depressive disorder (DSM-IV);
You may not qualify if:
- Acute psychotic symptoms;
- Acute suicidal intent (within 48 hours);
- Unable to walk for 60 min or serious medical reasons (e.g. major surgery)
- Heart condition as per history or detected on electrocardiogram
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Douglas Mental Health University Institute
Montreal, Quebec, H4H 1R3, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marie-Claude Geoffroy, PhD
McGill University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Participants were unaware as to whether they were assigned to an urban or nature walking condition
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
June 18, 2019
First Posted
June 25, 2019
Study Start
June 18, 2019
Primary Completion
September 3, 2021
Study Completion
September 3, 2021
Last Updated
November 12, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share